Abstract
Importance Outpatient physicians need guidance to support their clinical decisions regarding management of patients with COVID-19, specifically whether to hospitalize a patient or if managed as an outpatient, how closely to follow them.
Objective To develop and prospectively validate a clinical prediction rule to predict the likelihood of hospitalization for outpatients with COVID-19 that does not require laboratory testing or imaging, including during the current Omicron wave.
Design Derivation and temporal validation of a clinical prediction rule, and prospective validation of two externally derived clinical prediction rules.
Setting Primary and urgent care clinics in a Pennsylvania health system.
Participants Patients 12 years and older presenting to outpatient clinics who had a positive polymerase chain reaction test for COVID-19.
Main outcomes and measures Classification accuracy (percentage in each risk group hospitalized) and area under the receiver operating characteristic curve (AUC).
Results Overall, 4.0% of outpatients in the early derivation cohort (5843 patients presenting before 3/1/21), 4.2% in the late validation cohort (3806 patients presenting 3/1/21 to 9/30/21), and 1.9% in an Omicron cohort were ultimately hospitalized. We developed and temporally validated four simple risk scores. The base score included age, dyspnea, and the presence of a comorbidity, with the other scores adding fever, respiratory rate and/or oxygen saturation. All had very good overall accuracy (AUC 0.85-0.87) and classified at least half of patients into a low risk with a < 1% likelihood of hospitalization. Hospitalization rates in the Omicron cohort were 0.22%, 1.3% and 8.7% for the base score. Two externally derived risk scores identified more low risk patients, but with a higher overall risk of hospitalization than our novel risk scores.
Conclusions and relevance A simple risk score applicable to outpatient and telehealth settings can classify over half of COVID-19 outpatients into a very low risk group with a 0.22% hospitalization risk in the Omicron cohort. The Lehigh Outpatient COVID Hospitalization (LOCH) risk score is available online as a free app: https://ebell-projects.shinyapps.io/LehighRiskScore/.
Question Is it possible to predict the eventual likelihood of hospitalization for outpatients with COVID-19 using simple non-laboratory based risk scores?
Findings We created and temporally validated in the same population 4 risk scores with 3 to 5 predictors that do not require laboratory testing. Groups with low (0.34% to 0.89%), moderate (4.0% to 6.2%), and high-risk (19.2% to 25.2%) of hospitalization were identified. The risk scores were also accurate in an Omicron dominant cohort with hospitalization rates of 0.22% to 0.43% in the low-risk groups, 1.3% to 1.7% in the moderate risk groups, and 8.7% to 15.3% in the high risk groups.
Meaning Simple risk scores can help support decisions about hospitalization in the outpatient setting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Subjects Office of the University of Georgia gave ethical approval for this study (PROJECT00004060).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We have added data validating the risk scores in a cohort of patients when the Omicron variant was dominant in the US, from 12/20/21 to 1/21/22. We also now limit hospitalization to within 28 days of the index outpatient visit.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
